HilleVax, Inc. financial data

Location
Boston, MA
Fiscal year end
31 December
Latest financial report
10-Q - Q2 2025 - 06 Aug 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1637% % 71%
Debt-to-equity 20% % -30%
Return On Equity -45% % 28%
Return On Assets -37% % 23%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 50,141,064 shares 0.72%
Common Stock, Shares, Outstanding 50,125,541 shares 1.7%
Common Stock, Value, Issued $5,000 USD 0%
Weighted Average Number of Shares Outstanding, Basic 50,114,308 shares 1.9%
Weighted Average Number of Shares Outstanding, Diluted 50,114,308 shares 1.9%

Income Statement

Label TTM Value / Value Unit Change %
General and Administrative Expense $23,444,000 USD -23%
Operating Income (Loss) $77,120,000 USD 54%
Nonoperating Income (Expense) $6,023,000 USD -44%
Net Income (Loss) Attributable to Parent $71,097,000 USD 55%
Earnings Per Share, Basic -1 USD/shares 58%
Earnings Per Share, Diluted -1 USD/shares 58%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $58,677,000 USD -46%
Marketable Securities, Current $100,870,000 USD -26%
Assets, Current $162,241,000 USD -36%
Property, Plant and Equipment, Net $4,026,000 USD -61%
Operating Lease, Right-of-Use Asset $6,990,000 USD -44%
Other Assets, Noncurrent $26,000 USD 13%
Assets $174,914,000 USD -37%
Accounts Payable, Current $113,000 USD -97%
Employee-related Liabilities, Current $579,000 USD 22%
Accrued Liabilities, Current $2,404,000 USD -85%
Liabilities, Current $6,147,000 USD -87%
Operating Lease, Liability, Noncurrent $19,912,000 USD -9.1%
Other Liabilities, Noncurrent $1,036,000 USD 10%
Liabilities $27,095,000 USD -62%
Accumulated Other Comprehensive Income (Loss), Net of Tax $1,239,000 USD -32%
Retained Earnings (Accumulated Deficit) $547,153,000 USD -15%
Stockholders' Equity Attributable to Parent $147,819,000 USD -28%
Liabilities and Equity $174,914,000 USD -37%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $12,718,000 USD 61%
Net Cash Provided by (Used in) Investing Activities $94,264,000 USD -63%
Common Stock, Shares Authorized 500,000,000 shares 0%
Common Stock, Shares, Issued 50,141,064 shares 0.72%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $106,982,000 USD -42%
Deferred Tax Assets, Valuation Allowance $81,348,000 USD 49%
Deferred Tax Assets, Gross $82,918,000 USD 42%
Operating Lease, Liability $23,542,000 USD -7.4%
Depreciation $1,470,000 USD -10%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $71,399,000 USD 54%
Lessee, Operating Lease, Liability, to be Paid $30,600,000 USD -11%
Property, Plant and Equipment, Gross $6,588,000 USD -46%
Operating Lease, Liability, Current $3,630,000 USD 3.2%
Lessee, Operating Lease, Liability, to be Paid, Year Two $3,793,000 USD 2.8%
Lessee, Operating Lease, Liability, to be Paid, Year One $1,849,000 USD 3.2%
Operating Lease, Weighted Average Discount Rate, Percent 0.07 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $7,058,000 USD -20%
Lessee, Operating Lease, Liability, to be Paid, Year Three $3,864,000 USD 2.1%
Deferred Tax Assets, Operating Loss Carryforwards $24,717,000 USD 139%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 50,000,000 shares 0%
Unrecognized Tax Benefits $976,000 USD 1.8%
Lessee, Operating Lease, Liability, to be Paid, Year Four $3,978,000 USD 3.1%
Operating Lease, Payments $923,000 USD 3%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance $1,570,000 USD -60%
Share-based Payment Arrangement, Expense $14,288,000 USD -25%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%